Rigel Pharmaceuticals Inc (RIGL) Event Dec. 02, 2022, 01:17 UTC Rigel Pharmaceuticals, Inc. REZLIDHIA™(olutasidenib) U.S. FDA Approval Call Full text
There are no comments here yet...